Fig. 22: Discussion on Digital Biomarker Research for Alzheimer’s Disease.
From: Alzheimer’s disease digital biomarkers multidimensional landscape and AI model scoping review
a The current multidimensional landscape of digital biomarkers in Alzheimer’s disease. b The five key dimensions of the challenges in clinical implementation of digital biomarkers. c The relationship between the main challenges, current status, and future prospects in the field of digital biomarkers for AD. The color of the circles represents the hierarchical relationships of the topics, while the arrows indicate the connections and directional relationships between all topics.
